September 27th, 2024 “EURETINA-Brief”© Issue No. 300
Dear EURETINA Members, A very warm welcome to the September 27th, 2024 edition of EURETINA’s web-based digital periodical, “EURETINA Brief”. EURETINA are delighted to continue…
EURETINA’s
DIGITAL
NEWSLETTER
Featured Articles
1
September 27th, 2024
Latest News
September 27th, 2024 “EURETINA-Brief”© Issue No. 300
Dear EURETINA Members, A very warm welcome to the September 27th, 2024 edition of EURETINA’s…
EURETINA announce the inaugural Ramin Tadayoni Award for Dr. Andrea Govetto, MD, PhD, based in Milan, Italy.
Sept. 19th, 2024 – On the first day of the EURETINA Congress in Barcelona, Prof.…
Clinical trial endpoints use EZ and ELM biomarkers for selecting patients for treatments on X-linker retinitis pigmentosa.
Researchers at Nuffield Laboratory of Ophthalmology, University of Oxford and the Oxford Eye Hospital, NHS…
HuidaGene Therapeutics presents a novel AAV9 RPE-65 treatment for Leber congenital amaurosis at EURETINA Congress in Barcelona.
HuidaGene Therapeutics, based in Shanghai, China and Clinton, New Jersey, have reported preliminary data on…